Critical Care Utilization in Children With Cancer: U.S. Pediatric Health Information System Database Cohort 2012-2021

Colin M Rogerson1, Courtney M Rowan

  • 1Both authors: Division of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.

Insights

Pediatric oncology hospitalizations requiring intensive care increased from 2012-2021. Despite higher acuity, pediatric intensive care unit (PICU) admission was linked to decreased mortality rates.

Area of Science:

  • Pediatric critical care medicine
  • Pediatric oncology
  • Health services research

Background:

  • Pediatric oncology hospitalizations have seen significant advancements in treatment and survival over the past decade.
  • Understanding trends in intensive care utilization is crucial for resource allocation and quality improvement in pediatric cancer care.

Purpose of the Study:

  • To analyze trends in pediatric oncology hospitalizations requiring admission to the pediatric intensive care unit (PICU) between 2012 and 2021.
  • To evaluate changes in the utilization of critical care support and associated mortality rates over the study period.

Main Methods:

  • A retrospective analysis of hospital admission data was conducted.
  • Data were sourced from the U.S. Pediatric Health Information Systems database, encompassing 36 children's hospitals.
  • The study included 281,221 hospitalizations for patients aged 18 years or younger with an oncology diagnosis.

Main Results:

  • Pediatric oncology hospitalizations and PICU admissions increased steadily from 2012 to 2021.
  • The proportion of oncology hospitalizations admitted to the PICU rose from 15.1% (2012-2016) to 18.0% (2017-2021).
  • Despite increased acuity markers and PICU utilization, the overall case fatality rate remained stable at 1.3%, with lower mortality odds associated with PICU admission in the later period.

Conclusions:

  • There has been a significant increase in the percentage of pediatric oncology hospitalizations requiring PICU admission over the last decade.
  • Increased PICU admission and markers of acuity were observed, yet mortality rates showed a favorable trend.
  • PICU admission during 2017-2021 was associated with reduced mortality compared to 2012-2016, suggesting improved outcomes despite higher critical care needs.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
365
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
252
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
12
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K